Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 13, 2020 08:00 ET | Source: Nurix

Nurix Therapeutics Announces Addition of Dr. Jason Kantor to its Management Team

SAN FRANCISCO, July 13, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing targeted protein modulation drugs, today announced the appointment of Dr. Jason Kantor as senior vice...
June 16, 2020 08:00 ET | Source: Nurix

Nurix Therapeutics Announces Addition of Immuno-Oncology Clinical Experts to its Management Team

SAN FRANCISCO, June 16, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing targeted protein modulation drugs, today announced the appointment of Dr. Michael T. Lotze as chief...
March 12, 2020 08:00 ET | Source: Nurix

Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline

SAN FRANCISCO, March 12, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing targeted protein modulation drugs, today announced it has closed an oversubscribed $120 million...
February 27, 2020 08:00 ET | Source: Nurix

Nurix Therapeutics to Present at the Cowen & Co. 40th Annual Health Care Conference

SAN FRANCISCO, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing targeted protein modulation drugs, today announced that CEO Arthur Sands will present at the Cowen...
January 09, 2020 08:00 ET | Source: Nurix

Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies

SAN FRANCISCO, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company researching novel therapies that control degradation of disease-causing proteins, today announced a global...
January 08, 2020 08:00 ET | Source: Nurix

Nurix Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing targeted protein modulation drugs announced today that CEO Arthur Sands will present at the 38th...
November 18, 2019 08:00 ET | Source: Nurix

Nurix Therapeutics Announces Scientific Presentations on its BTK Program at the 61st American Society of Hematology Annual Meeting

SAN FRANCISCO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing novel therapies that control disease-causing proteins, today announced an oral presentation on its...
November 14, 2019 08:00 ET | Source: Nurix

Nurix Therapeutics Announces Key Management Additions

SAN FRANCISCO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing therapies that control disease-causing proteins, today announced the appointment of Dr. Christine Ring...
November 12, 2019 08:00 ET | Source: Nurix

Nurix Therapeutics Announces Upcoming Investor Conference Schedule

SAN FRANCISCO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing therapies that control disease-causing proteins, today announced that the Company management team will...
October 22, 2019 08:00 ET | Source: Nurix

Nurix Therapeutics Announces Upcoming Scientific Presentation for its CBL-B Program at the Society for Immunotherapy of Cancer 34th Annual Meeting (SITC 2019)

SAN FRANCISCO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing therapies that control disease-causing proteins, today announced that it will present data on its...